Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,424.00
Ask: 12,426.00
Change: 58.00 (0.47%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,470.00
Low: 12,322.00
Prev. Close: 12,346.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks rise as upbeat forecast from Volkswagen spurs rally in autos

Tue, 16th Mar 2021 09:23

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* European autos sector touches highest level since June
2018

* Zalando at 3-week peak, retail sector hits record high

* Volkswagen says cost cuts to boost margin, shares jump

* European stocks volatility gauge at February 2020 lows
(Adds analyst comments, updates prices throughout)

By Shreyashi Sanyal

March 16 (Reuters) - European stocks rose on Tuesday as an
upbeat forecast from German carmaker Volkswagen prompted a rally
in the automobiles sector, while investors awaited the U.S.
Federal Reserve's views on a recent pickup in inflation.

The pan-European STOXX 600 index rose 0.9%, inching
closer to a record peak set last year, while the regional autos
sector jumped 2.1% to its highest level since June 2018.

Leading gains among autos was Volkswagen AG
which jumped 6.7% after it said it was confident that cost cuts
will help improve profit margins in the coming years.

"There is something to do with more interest as global
investors are becoming more attracted to areas outside of
technology which would include sectors like autos, mining and
industrials," said Chris Bailey, European strategist at Raymond
James.

"Particularly for autos it is a combination of higher demand
as economies recover and also these are companies with proper
international businesses."

Zalando rose 5.0% after it forecast 2021 revenue
growth above market expectations following a strong start to the
year. Its shares touched a three-week high and lifted the wider
retail index.

A gauge of volatility in European stock markets
slipped to its lowest level in over one year.

Investors are focused on the Fed's two-day policy meeting,
which will end on Wednesday amid concerns that a potential spike
in inflation as economies recover could prompt the central bank
to tighten monetary policy sooner than expected.

Official data showed French final inflation rose largely in
line with estimates in February. Meanwhile, the ZEW economic
research institute said investor sentiment in Germany increased
by more than expected in March, buoying the outlook for a
broad-based recovery in Europe's largest economy.

While optimism about an economic recovery has pushed markets
to near-record highs, concerns remain about the pace of COVID-19
vaccination in Europe, with Sweden becoming the latest country
to pause AstraZeneca's vaccine after several countries
reported possible serious side-effects.

Deutsche Bank slashed 2021 economic growth forecasts for the
euro area by a percentage point, citing spillover of the ongoing
pandemic-linked activity curbs, but raised predictions for
Britain, the United States and India.

French telecoms operator Iliad SA jumped almost
4.5% after saying it aimed to turn a core profit for its Italian
business in the second half of this year.

German biotech firm Morphosys slumped
10.6????????% to the bottom of STOXX 600 after forecasting a
fall in 2021 revenue.
(Reporting by Sruthi Shankar and Devik Jain in Bengaluru
Editing by Arun Koyyur and Matthew Lewis)

More News
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Read more
3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.

Read more
2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug, according to trial results announced on Sunday.

Read more
2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by about five months for people with low levels of HER2 protein whose cancer progressed following endocrine therapy, according to research presented on Sunday.

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.